Press Releases
SAN DIEGO, Jan. 13, 2020 /PRNewswire/ -- Neurelis, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved VALTOCO® (diazepam nasal spray) as an acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct from a patient's usual
Read more...13 January 2020
NEW YORK and GAINESVILLE, Fla., Jan. 13, 2020 /PRNewswire/ -- The Muscular Dystrophy Association (MDA) and AavantiBio, a biotechnology company developing a gene-targeting therapy for Friedreich's ataxia (FA), today announced the award of MDA Venture Philanthropy (MVP) funding totaling $1,076,232 to advan
Read more...13 January 2020
LOS ANGELES, Jan. 13, 2020 /PRNewswire/ -- Tonight, Mental Health for US is hosting the Unite for Change Forum: California featuring NBC News' Kate Snow, actress, singer-songwriter, and mental health advocate Kiana Ledé, and former U.S. Rep. Patrick J. Kennedy. The event, taking place at the University of
Read more...13 January 2020
BOSTON, Jan. 13, 2020 /PRNewswire/ -- Medisafe, a leading evidenced-based digital therapeutics company collaborating with healthcare organizations to provide medication management solutions
Read more...13 January 2020
NEW YORK, Jan. 13, 2020 /PRNewswire/ -- Aidoc, the leading provider of AI solutions for radiologists, today announced that the US Food and Drug Administration (FDA) has cleared its AI solution for flagging Large-Vessel Occlusion (LVO) in head CTA scans, marking Aidoc's fourth FDA-clea
Read more...SAN FRANCISCO, Jan. 13, 2020 /PRNewswire/ -- Lark Health, the leading digital chronic disease management and prevention platform, today announced that it has been named by FierceHealthcare as one of the 2020 Fierce 15 companies, designating it as one of the most promising healthcare companies in the industry.
Read more...13 January 2020
AUSTIN, Texas, Jan. 13, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today provided an update on its Nu Q™ Clinical Assays which use a magnetic particle-based assay format. Volition has completely re-engineered its Nu.Q™ assays leading to a step-change improvement in analytical performance. Volition expects this e
Read more...13 January 2020
CLEVELAND, Jan. 13, 2020 /PRNewswire/ -- Hyland Healthcare, a leading global provider of content services and enterprise imaging, is unveiling
Read more...13 January 2020
ABBOTT PARK, Ill., Jan. 13, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved a first-of-its-kind clinical trial that will compare the effectiveness of Abbott's minimally invasive MitraClip™ device – which has now treated 100,000 patients worldwide – to open heart mitral valve surgical repair in people with primar
Read more...13 January 2020
SALT LAKE CITY, Jan. 13, 2020 /PRNewswire/ -- A 17-year-old male patient with a severed extensor tendon of his thumb due to traumatic injury became the first outside of a clinical trial to undergo tendon repair with CoNextions Medical's TR Tendon Repair device since the product's recent approval in Chile, the first country to approve the
Read more...